Search research articles
Contact Us
Filters
Showing results (21-30 of 50) with videos related to
Page
of 5
Sort By:
Journal of Neuroengineering and Rehabilitation
|
September 27, 2018
The role of exercise testing in predicting successful ambulation with a lower extremity prosthesis: a systematic literature review and clinical practice guideline
Tyler D Klenow, Larry J Mengelkoch, Phillip M Stevens, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 29, 2014
Clinical efficacy and safety in relapsed/refractory diffuse large B-cell lymphoma: a systematic literature review
Ann Colosia, Annete Njue, Peter C Trask, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 24, 2014
Clinical efficacy and safety in relapsed/refractory mantle cell lymphoma: a systematic literature review
Annete Njue, Ann Colosia, Peter C Trask, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 29, 2016
Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study
Kathleen N Moore, Lainie P Martin, David M O'Malley, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
August 31, 2015
Randomized controlled trials in relapsed/refractory follicular lymphoma: a systematic review and meta-analysis
Rachel L Police, Peter C Trask, Jianmin Wang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 6, 2014
Phase I safety and pharmacokinetic study of the PI3K/mTOR inhibitor SAR245409 (XL765) in combination with erlotinib in patients with advanced solid tumors
Pasi A Jänne, Roger B Cohen, A Douglas Laird, et al.
Future Oncology (London, England)
|
November 23, 2019
Intrigue: Phase III study of ripretinib versus sunitinib in advanced gastrointestinal stromal tumor after imatinib
John Nemunaitis, Sebastian Bauer, Jean-Yves Blay, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 3, 2014
Randomized controlled trials in relapsed/refractory chronic lymphocytic leukemia: a systematic review and meta-analysis
Rachel L Police, Peter C Trask, Jianmin Wang, et al.
Gynecologic Oncology
|
August 28, 2017
Characterization of folate receptor alpha (FRα) expression in archival tumor and biopsy samples from relapsed epithelial ovarian cancer patients: A phase I expansion study of the FRα-targeting antibody-drug conjugate mirvetuximab soravtansine
Lainie P Martin, Jason A Konner, Kathleen N Moore, et al.
Foods (Basel, Switzerland)
|
October 26, 2024
Purchase Intention of Healthy Foods: The Determinant Role of Brand Image in the Market of a Developing Country
Elizabeth Emperatriz García-Salirrosas, Manuel Escobar-Farfán, Iván Veas-González, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 50) with videos related to
Sort By:
Page
of 5
Journal of Neuroengineering and Rehabilitation
|
September 27, 2018
The role of exercise testing in predicting successful ambulation with a lower extremity prosthesis: a systematic literature review and clinical practice guideline
Tyler D Klenow, Larry J Mengelkoch, Phillip M Stevens, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 29, 2014
Clinical efficacy and safety in relapsed/refractory diffuse large B-cell lymphoma: a systematic literature review
Ann Colosia, Annete Njue, Peter C Trask, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 24, 2014
Clinical efficacy and safety in relapsed/refractory mantle cell lymphoma: a systematic literature review
Annete Njue, Ann Colosia, Peter C Trask, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 29, 2016
Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study
Kathleen N Moore, Lainie P Martin, David M O'Malley, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
August 31, 2015
Randomized controlled trials in relapsed/refractory follicular lymphoma: a systematic review and meta-analysis
Rachel L Police, Peter C Trask, Jianmin Wang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 6, 2014
Phase I safety and pharmacokinetic study of the PI3K/mTOR inhibitor SAR245409 (XL765) in combination with erlotinib in patients with advanced solid tumors
Pasi A Jänne, Roger B Cohen, A Douglas Laird, et al.
Future Oncology (London, England)
|
November 23, 2019
Intrigue: Phase III study of ripretinib versus sunitinib in advanced gastrointestinal stromal tumor after imatinib
John Nemunaitis, Sebastian Bauer, Jean-Yves Blay, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 3, 2014
Randomized controlled trials in relapsed/refractory chronic lymphocytic leukemia: a systematic review and meta-analysis
Rachel L Police, Peter C Trask, Jianmin Wang, et al.
Gynecologic Oncology
|
August 28, 2017
Characterization of folate receptor alpha (FRα) expression in archival tumor and biopsy samples from relapsed epithelial ovarian cancer patients: A phase I expansion study of the FRα-targeting antibody-drug conjugate mirvetuximab soravtansine
Lainie P Martin, Jason A Konner, Kathleen N Moore, et al.
Foods (Basel, Switzerland)
|
October 26, 2024
Purchase Intention of Healthy Foods: The Determinant Role of Brand Image in the Market of a Developing Country
Elizabeth Emperatriz García-Salirrosas, Manuel Escobar-Farfán, Iván Veas-González, et al.
Page
of 5